Noninflammatory disorders of female genital tract. Complication associated with artificial fertilization, unspecified
Conditions
Interventions
Intervention 1: Intervention 1: Injection of normal saline into the uterus on day 21 to 22 of the menstrual cycle (intrauterine insemination catheter, Cook Company, USA) and examine the uterine flushi
Diagnosis
Intervention 1: Injection of normal saline into the uterus on day 21 to 22 of the menstrual cycle (intrauterine insemination catheter, Cook Company, USA) and examine the uterine flushing and blood sam
Intervention 2: Injection of normal saline into the uterus on day 21 to 22 of the menstrual cycle (intrauterine insemination catheter, Cook Company, USA) and examine the uterine flushing and blood sam
Sponsors
Vice chancellor for research, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Forty women aged 20 to 40 years; in vitro fertilization failure in half of them (at least 2 cycles of in vitro fertilization failure) ; lack of polyps or uterine fibroids. Exclusion criteria: Presence of uterine polyps or fibroids; history of hormone use in the past two months; active vaginal infection.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum glycodelin concentrations. Timepoint: On day 21-22 of menstrual cycles. Method of measurement: Laboratory kits.;Uterine flushing glycodelin concentrations. Timepoint: On day 21-22 of menstrual cycles. Method of measurement: Laboratory kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Zamaniyan
Reproductive and Infertility Health Research Center, Shahid Beheshti University of Medical Sciences,
Outcome results
None listed